Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
05/2011
05/25/2011CN101690777B Formula of polygonatum chewable tablets and preparation method thereof
05/25/2011CN101664386B Enrofloxacin double emulsion for livestock and preparation method thereof
05/25/2011CN101642549B Preparation method of compound fresh bamboo juice
05/25/2011CN101637452B Atorvastatin calcium dried suspension and preparation method thereof
05/25/2011CN101628097B Stomach health powder
05/25/2011CN101584672B Clofarabine pharmaceutical composition freeze-dried powder injection and preparation method thereof
05/25/2011CN101579455B Traditional Chinese medicine preparation for treating consumptive disease
05/25/2011CN101579325B Metformin hydrochloride controlled-release tablet and preparation method thereof
05/25/2011CN101579315B Immunoliposome based on endostatin gene, preparation method and application thereof
05/25/2011CN101559231B High shearing production method for film coating agent
05/25/2011CN101559045B Arachidonic acid nutrition microcapsule with high temperature resistance and preparation method thereof
05/25/2011CN101554443B Traditional Chinese medicine for treating angina
05/25/2011CN101543601B Compound pharmaceutical composition for preventing and curing respiratory diseases in animals and preparation method thereof
05/25/2011CN101543553B Traditional Chinese medicine composition for regulating qi-flowing and relieving chest stuffiness and pain
05/25/2011CN101519451B Recombinant human cytotoxic T lymphocyte associate antigen-4 fusion protein gene (sCTLA4-Ig) and pharmaceutical composition thereof
05/25/2011CN101518575B Traditional Chinese medicine for treating diabetic insomnia
05/25/2011CN101461879B Plaster for treating neck, spine, protrusion of lumbar vertebral disc, hyperosteogeny, arthralgia and myalgia
05/25/2011CN101455729B Kangfulingshuan medicine production technique
05/25/2011CN101444527B Medicament for curing oral ulcer
05/25/2011CN101420946B Tamsulosin-containing percutaneous absorption type preparation
05/25/2011CN101406583B Externally applied Chinese medicine ointment for treating pyogenic skin infection caused by skin traumatism
05/25/2011CN101401789B Cordyceps sinensis polysaccharide liposome medicament and preparation thereof
05/25/2011CN101371916B Preparation method of gongyankang dropping pill formulation
05/25/2011CN101361839B Quality control detection method of Xuefu Zhuyu oral liquid
05/25/2011CN101322784B Medicament with stomach-regulating and antidiarrheal efficacy and producing method thereof
05/25/2011CN101310739B Cassia Tuckahoe composition and preparation method thereof
05/25/2011CN101293081B Medicament for treating hyperlipemia and preparation method thereof
05/25/2011CN101292969B Application of butyric acid (butanoic acid) in preparing medicaments for treating anorectal diseases
05/25/2011CN101278963B Liquid medicament for curing bedsore
05/25/2011CN101259102B Micrometre level docosahexaenoic acid emulsion and preparation thereof
05/25/2011CN101239135B Functional food for improving intestinal canal function and auxiliary treating coprostasis
05/25/2011CN101239120B Yixueling tablet
05/25/2011CN101239112B Chinese medicinal composition for regulating blood fat and preparation thereof
05/25/2011CN101219201B Traditional Chinese medicine liquid capsule and its preparing method
05/25/2011CN101219118B Impulse released oral medication preparation
05/25/2011CN101194995B Proprietary Chinese medicine for treating animal virus, bacterium and mix infection
05/25/2011CN101185759B Anti-angiogene compositions and methods of use
05/25/2011CN101167862B Traditional Chinese medicine compound preparation for treating diabetes and nephrosis and preparing method thereof
05/25/2011CN101152262B Anti-gout novel medical preparation
05/25/2011CN101152255B Method of preparing aqueous extract concrete of ficus microcarpa leaf
05/25/2011CN101143154B Method for preparing surface cladding super-micro traditional Chinese medicine material crude slice
05/25/2011CN101115473B Confectionery products containing caffeine
05/25/2011CN101094652B Biodegradable cross-linked cationic multi-block copolymers for gene delivery and methods of making thereof
05/25/2011CN101007169B A microcapsule of egg yolk immunoglobulin, preparing process and use thereof
05/25/2011CN101007091B A traditional Chinese medicine compound preparation for treating primary dysmenorrhea
05/24/2011US7948148 Piezoelectric transducer
05/24/2011US7947976 Controlled alignment of catalytically grown nanostructures in a large-scale synthesis process
05/24/2011US7947744 Stable pharmaceutical products
05/24/2011US7947742 For treatment of anaphylaxis/respiratory system disorders; spray drying; improved bioavailability
05/24/2011US7947725 Liquid pharmaceutical formulations of palonosetron
05/24/2011US7947724 Liquid pharmaceutical formulations of palonosetron
05/24/2011US7947659 iRNA agents targeting VEGF
05/24/2011US7947654 Pharmaceutical formulations
05/24/2011US7947309 Use of hyaluronic acid polymers for mucosal delivery of vaccine antigens and adjuvants
05/24/2011US7947308 Effervescent powders for inhalation
05/24/2011US7947307 Methods and compositions for imaging
05/24/2011US7947306 Modifications of solid 3-sn-phosphoglycerides
05/24/2011US7947305 Fat-soluble drug composition
05/24/2011US7947303 Supplement to be enterally administered for parenteral nutrition or partial enteral/oral nutrition of the critically ill, the chronically ill and people with malnutrition
05/24/2011US7947299 Compositions and techniques for localized therapy
05/24/2011US7947295 Ophthalmic compositions containing a synergistic combination of two polymers
05/24/2011US7947293 Aqueous pharmaceutical formulation
05/24/2011US7947292 Bacteria trapping fibrous material
05/24/2011US7947257 Method of intranasal administration of granisetron
05/24/2011US7946849 Characterization of an antibiotic impregnated delivery system as an intracanal medicament in endodontic therapy
05/24/2011CA2633170C Butylphthalide intravenous emulsion and application thereof
05/24/2011CA2624589C Neramexane modified release matrix tablet
05/24/2011CA2582767C Solid formulation with improved solubility and stability and method for producing said formulation
05/24/2011CA2531239C Pharmaceutical formulations for intranasal administration of protein comprising a chitosan or a derivative thereof
05/24/2011CA2509023C Multilayer dosage forms containing nsaids and triptans
05/24/2011CA2499195C A treatment solution and method for preventing posterior capsular opacification by selectively inducing detachment and/or death of lens epithelial cells
05/24/2011CA2493764C Improved treatment of cancer with glutamine
05/24/2011CA2491313C Non-polymeric lipophilic pharmaceutical implant compositions for intraocular use
05/24/2011CA2490007C Biodegradable triblock copolymers, synthesis methods therefor, and hydrogels and biomaterials made there from
05/24/2011CA2489665C Popping oral administration form
05/24/2011CA2489513C Edible inks for ink-jet printing on edible substrates
05/24/2011CA2479737C Nanoparticulate compositions of map kinase inhibitors
05/24/2011CA2463495C Compositions having a combination of immediate release and controlled release characteristics
05/24/2011CA2454331C Method and apparatus for preparing particles
05/24/2011CA2452412C Biodegradable injectable implants and related methods of manufacture and use
05/24/2011CA2441123C A pharmaceutical tablet system that floats on gastric fluid for multipulse release of active substance, and respective processes of producing same and a cup-shaped envelope of same
05/24/2011CA2428985C Improved ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers
05/24/2011CA2425788C Film for active ingredients dermal and transdermal administration
05/24/2011CA2420621C Microparticle compositions and methods for the manufacture thereof
05/24/2011CA2415403C Method for obtaining aqueous formulations of oxidation-sensitive active principles
05/24/2011CA2382840C Improved topical compositions containing probiotic bacteria, spores, and extracellular products and uses thereof
05/24/2011CA2366090C Composition and method for inducing apoptosis in prostate cancer cells
05/24/2011CA2358459C Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
05/24/2011CA2345277C Methods for isolation, quantification, characterization and modulation of antigen-specific t cells
05/24/2011CA2344816C Medicinal aerosol formulation
05/24/2011CA2341642C Page-4, an x-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor
05/24/2011CA2258017C Immunstimulating lipid formulation
05/20/2011CA2721887A1 Medical pressure-sensitive adhesive composition
05/20/2011CA2721866A1 Patch and patch preparation
05/20/2011CA2719660A1 Oral dosage forms for delivery of therapeutic agents
05/19/2011WO2011060290A2 Immediate release tablet formulations
05/19/2011WO2011060256A2 Bilayer tablet formulations
05/19/2011WO2011060255A1 Reduced mass metformin formulations
05/19/2011WO2011060195A2 Topical eutectic formulation
05/19/2011WO2011060129A1 Dynamic thermoresponsive nanoparticles for stabilization of enzymes at high temperatures